These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10436255)

  • 1. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.
    Kado S; Nagase T; Nagata N
    Acta Diabetol; 1999 Jun; 36(1-2):67-72. PubMed ID: 10436255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H; Wiersbowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
    Nakamura A; Shikata K; Hiramatsu M; Nakatou T; Kitamura T; Wada J; Itoshima T; Makino H
    Diabetes Care; 2005 Dec; 28(12):2890-5. PubMed ID: 16306550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
    Robak T; Gladalska A; Stepień H; Robak E
    Mediators Inflamm; 1998; 7(5):347-53. PubMed ID: 9883970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma.
    Wierzbowska A; Urbańska-Ryś H; Robak T
    Br J Haematol; 1999 May; 105(2):412-9. PubMed ID: 10233412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients.
    Kovacs E
    Biomed Pharmacother; 2001 Sep; 55(7):391-6. PubMed ID: 11669502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis.
    Petrinović-Doresić J; Mazuran R; Henc-Petrinović L; Kuzmanović B; Jovicić A
    Ocul Immunol Inflamm; 1999 Jun; 7(2):75-84. PubMed ID: 10420202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction.
    Ueda K; Takahashi M; Ozawa K; Kinoshita M
    Am Heart J; 1999 Nov; 138(5 Pt 1):908-15. PubMed ID: 10539822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C
    Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes.
    Giuliani N; Sansoni P; Girasole G; Vescovini R; Passeri G; Passeri M; Pedrazzoni M
    Exp Gerontol; 2001 Mar; 36(3):547-57. PubMed ID: 11250125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.
    Pulsatelli L; Boiardi L; Assirelli E; Pazzola G; Muratore F; Addimanda O; Dolzani P; Versari A; Casali M; Magnani L; Pignotti E; Pipitone N; Croci S; Meliconi R; Salvarani C
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):102-110. PubMed ID: 28466804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemia.
    Hatzimichael EC; Christou L; Bai M; Kolios G; Kefala L; Bourantas KL
    Eur J Haematol; 2001 Jan; 66(1):1-6. PubMed ID: 11168500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-6 receptor as a prognostic factor in multiple myeloma. Finnish Leukaemia Group.
    Pulkki K; Pelliniemi TT; Rajamäki A; Tienhaara A; Laakso M; Lahtinen R
    Br J Haematol; 1996 Feb; 92(2):370-4. PubMed ID: 8603002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly.
    Abbatecola AM; Ferrucci L; Grella R; Bandinelli S; Bonafè M; Barbieri M; Corsi AM; Lauretani F; Franceschi C; Paolisso G
    J Am Geriatr Soc; 2004 Mar; 52(3):399-404. PubMed ID: 14962155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy.
    Hoheisel G; Izbicki G; Roth M; Chan CH; Reichenberger F; Schauer J; Perruchoud AP
    Respiration; 1998; 65(3):183-6. PubMed ID: 9670298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients.
    Dziedzic T; Gryz EA; Turaj W; Slowik A; Szczudlik A
    J Mol Neurosci; 2004; 24(2):293-8. PubMed ID: 15456942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-6 levels and bone mineral density at the femoral neck in post-menopausal women with Type 1 diabetes.
    Rachoń D; Myśliwska J; Suchecka-Rachoń K; Semetkowska-Jurkiewicz B; Zorena K; Łysiak-Szydłowska W
    Diabet Med; 2003 Jun; 20(6):475-80. PubMed ID: 12786682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab.
    Diaz-Torne C; Ortiz MDA; Moya P; Hernandez MV; Reina D; Castellvi I; De Agustin JJ; Fuente D; Corominas H; Sanmarti R; Zamora C; Cantó E; Vidal S
    Semin Arthritis Rheum; 2018 Jun; 47(6):757-764. PubMed ID: 29157669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.